CM
NTUS

Crestline Management’s Natus Medical Inc NTUS Stock Holding History

Crestline Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13,000
Closed -$334K – 115
2019
Q2 		$334K Buy
+13,000
New +$331K 0.05% 78

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Crestline Management's NTUS Position: Q3 2019 in Review

Crestline Management sold out of Natus Medical Inc (NTUS) in Q3 2019, closing a stake of 13,000 shares — an estimated $334K sold.

Crestline Management first reported a position in NTUS in Q2 2019 and held it in 1 quarter. The position peaked at $334K in Q2 2019. 168 funds tracked by Wall St. Rank hold NTUS as of Q3 2019.

  • Crestline Management reported no remaining Natus Medical Inc position as of Q3 2019 after selling out during the quarter.
  • Crestline Management sold 13,000 Natus Medical Inc shares in Q3 2019, an estimated $334K.
  • Crestline Management first reported a position in Natus Medical Inc in Q2 2019 and held it in 1 quarter.
  • Crestline Management's Natus Medical Inc position peaked at $334K in Q2 2019.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2019.

Based on Crestline Management's 13F filing for Q3 2019, filed 13 Nov 2019.